| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |